People: Stericycle Inc (SRCL.O)


SRCL.O on Nasdaq

110.88USD
18 Jun 2013
Price Change (% chg)

$1.55 (+1.42%)
Prev Close
$109.33
Open
$109.68
Day's High
$111.09
Day's Low
$109.54
Volume
560,043
Avg. Vol
405,939
52-wk High
$113.11
52-wk Low
$87.31

Search Stocks

Summary

Name Age Since Current Position

Mark Miller

57 2013 Executive Chairman of the Board

Charles Alutto

47 2013 President, Chief Executive Officer, Director

Frank ten Brink

56 1997 Chief Financial Officer, Executive Vice President, Chief Administrative Officer

Richard Kogler

53 2000 Chief Operating Officer, Executive Vice President

Michael Collins

56 2006 Executive Vice President, President - Recall and Returns Management Services

Jack Schuler

72 2008 Lead Independent Director

Thomas Brown

65 2008 Independent Director

Rodney Dammeyer

72 1998 Independent Director

William Hall

69 2006 Independent Director

Jonathan Lord

58 2004 Independent Director

John Patience

65 1989 Independent Director

Ronald Spaeth

69 2008 Independent Director

Michael Zafirovski

59 2012 Independent Director

Biographies

Name Description

Mark Miller

Mr. Mark C. Miller is Executive Chairman of the Board of Stericycle Inc. He has served as Executive Chairman since January 2013 and director as of May 1992. He became Chief Executive Officer in May 1992 and Chairman of the Board of Directors in August 2008. From May 1989 until joining, Mr. Miller served as vice president for the Pacific, Asia and Africa in the international division of Abbott Laboratories, a diversified health care company, which he joined in 1976 and where he held a number of management and marketing positions. Mr. Miller formerly served as a director of Ventana Medical Systems, Inc., a developer and supplier of automated diagnostic systems. He received a B.S. degree in computer science from Purdue University, where he graduated Phi Beta Kappa. Mr. Miller was selected by Morningstar, Inc. as its “2009 CEO of the Year.”

Charles Alutto

Mr. Charles A. Alutto is President, Chief Executive Officer, Director of Stericycle Inc. He is no longer President, Stericycle USA of the Company, effective January 1, 2013. He joined in May 1997 following acquisition of the company where he was then employed. He became an executive officer in February 2011 and served as President, Stericycle USA. He previously held various management positions with the Company, including vice president and managing director of SRCL Europe. Mr. Alutto received a B.S. degree in finance from Providence College and a M.B.A. degree in finance from St. John’s University.

Frank ten Brink

Mr. Frank J. M. ten Brink is Chief Financial Officer, Executive Vice President, Chief Administrative Officer of Stericycle Inc. Frank has served as Executive Vice President, Chief Financial Officer and Chief Administrative Officer since joining the Company in June 1997. He has over 16 years of finance experience in high growth environments, mergers and acquisitions. Prior to joining Stericycle, he was Senior Vice President and Chief Financial Officer with Telular Corporation. Between 1991 and 1995, he was Vice President and Chief Financial Officer of Hexacomb Corporation. Mr. ten Brink studied International Business at the Netherlands School of Business and received an M.B.A. degree in Finance from the University of Oregon.

Richard Kogler

Mr. Richard T. Kogler is Chief Operating Officer, Executive Vice President of Stericycle Inc. Mr. Kogler joined as Chief Operating Officer in December 1998. From May 1995 through October 1998, Mr. Kogler was Vice President and Chief Operating Officer of American Disposal Services, Inc., a solid waste management company. From October 1984 through May 1995, Mr. Kogler served in a variety of management positions with Waste Management, Inc. Mr. Kogler received a B.A. degree in chemistry from St. Louis University.

Michael Collins

Mr. Michael J. Collins is Executive Vice President, President - Recall and Returns Management Services of Stericycle Inc. He was most recently Vice President, Medical Products Group of Abbott Laboratories. He joined Abbott in 1982 as a sales representative and later served in various management positions, including Divisional Vice President, U.S. Sales; Divisional Vice President, U.S. Marketing, Divisional Vice President and General Manager, MediSense and Corporate Vice President Abbott Diagnostics Divisions. Mr. Collins was a commissioned officer for the U.S. Marine Corps. He earned a bachelor’s degree from the University of New Haven and a master’s degree in business administration from National University, San Diego.

Jack Schuler

Mr. Jack W. Schuler is Lead Independent Director Stericycle Inc. He has served as the Lead Director of Board of Directors since August 2008 and served as Chairman of the Board from January 1990 until becoming Lead Director. From January 1987 to August 1989 he served as president and chief operating officer of Abbott Laboratories, a diversified health care company, where he served as a director from April 1985 to August 1989. Mr. Schuler serves as a director of Medtronic, Inc., a medical technology company, Quidel Corporation, a developer and manufacturer of point-of-care diagnostic tests, and Accelerate Diagnostics, Inc., a developer of automated diagnostics systems, and formerly served as chairman of the board of directors of Ventana Medical Systems, Inc., and as a director of Amgen Incorporated, Chiron Corporation, Elan Corporation, plc, and ICOS Corporation. He is a co-founder of Crabtree Partners LLC, a private investment firm in Lake Forest, Illinois, and is a trustee of Carleton College. Mr. Schuler received a B.S. degree in mechanical engineering from Tufts University and a M.B.A. degree from the Stanford University Graduate School of Business Administration.

Thomas Brown

Mr. Thomas D. Brown is Independent Director of Stericycle Inc., since May 2008. From 1974 until his retirement in 2002, Mr. Brown held various sales, marketing and management positions at Abbott Laboratories, where he served as a senior vice president and president of the diagnostics division from 1998 to 2002 and as corporate vice president for worldwide commercial operations from 1993 to 1998. He is a director of Quidel Corporation and Cepheid, a molecular diagnostics company, and formerly served as a director of Ventana Medical Systems, Inc. Mr. Brown received a B.A. degree from the State University of New York at Buffalo.

Rodney Dammeyer

Mr. Rodney F. Dammeyer is Independent Director of Stericycle Inc., since January 1998. He is the chairman of CAC, LLC, a private company providing capital investment and management advisory services, and is the former vice chairman of Anixter International, where he served from 1985 until February 2001, and the former managing partner of corporate investments of Equity Group Investments, L.L.C., where he served from 1995 until June 2000. Mr. Dammeyer serves as a director of Quidel Corporation, a developer and manufacturer of point-of-care diagnostic tests, and as an independent trustee of various Invesco Van Kampen mutual funds, and formerly served as a director of Ventana Medical Systems, Inc. prior to its being acquired in February 2008 and as a director of The Scripps Research Institute. Mr. Dammeyer received a B.S. degree in accounting from Kent State University.

William Hall

Mr. William K. Hall is Independent Director of Stericycle Inc., since August 2006. He is a private equity investor who served from 2000 to 2009 as chairman of the board and chief executive officer of Procyon Technologies, Inc., a privately-owned holding company. From 1994 to 2000, Mr. Hall was chairman and chief executive officer of Falcon Building Products, Inc., a manufacturer and distributor of residential and commercial construction and home improvement products. He serves as a director of Actuant Corporation, a diversified industrial products manufacturer, A.M. Castle & Co., a specialty metals and plastics distributor, and W.W. Grainger, a supplier of facilities maintenance products, and as a trustee of the Rush University Medical Center. Mr. Hall received a B.S.E. degree in aeronautical engineering, a M.S. degree in mathematical statistics, and M.B.A. and Ph.D. degrees in business from the University of Michigan.

Jonathan Lord

Dr. Jonathan T. Lord, M.D., is Independent Director of Stericycle Inc. since August 2004. He has served as a director of Dexcom, Inc., a developer of glucose sensing technologies, since May 2008 and since May 2010 has served as its chairman of the board. From May 2009 to January 2010, he served as president and chief executive officer of Navigenics, Inc., a privately-held personal genomics testing company. Prior to joining Navigenics, Inc., Dr. Lord was chief innovation officer/senior vice president at Humana Inc., a health benefits company, which he joined in April 2000. From October 1999 to April 2000, he served as president of Health Dialog Services Corporation, a health information provider, and from April 1997 to October 1999, he served as chief operating officer of the American Hospital Association, a national organization representing hospitals, health care networks and their patients. He serves as a director of Dexcom, Inc., a developer of glucose sensing technologies, and formerly served as a director of Neurometrix, Inc. Dr. Lord received a B.S. degree in chemistry and a M.D. degree from the University of Miami.

John Patience

Mr. John Patience is Independent Director of Stericycle Inc., since March 1989. He is a co-founder and partner of Crabtree Partners LLC, a private investment firm in Lake Forest, Illinois, which was formed in June 1995. He formerly served as a director and vice chairman of the board of directors of Ventana Medical Systems, Inc., a public company prior to its being acquired in January 2008. From January 1988 to March 1995, he was a general partner in a venture capital firm which he co-founded and which led pre-IPO funding. He was previously a partner in the consulting firm of McKinsey & Company, specializing in health care. Mr. Patience received B.A. and LL.B. degrees from the University of Sydney in Sydney, Australia, and a M.B.A. degree from the Wharton School of Business of the University of Pennsylvania.

Ronald Spaeth

Mr. Ronald G. Spaeth is Independent Director of Stericycle Inc., since May 2008. He served as president of Evanston Northwestern Healthcare Foundation from 2002 to 2007 and as the president and chief executive officer of Highland Park (Illinois) Hospital from 1983 to 2002. He serves as a director of several private companies. Mr. Spaeth was formerly a director of Cole Taylor Bank and a member of the board of commissioners of the Joint Commission on the Accreditation of Healthcare Organizations, a member of the board of trustees of the American Hospital Association, chairman of the board of trustees of the Illinois Hospital Association and chairman of the board of governors of the American College of Healthcare Executives. He received a B.S. degree from Case Western Reserve University and a M.B.A. degree from the University of Chicago Graduate School of Business.

Michael Zafirovski

Mr. Michael S. Zafirovski is Independent Director of Stericycle, Inc. Mr. Zafirovski is the founder and president of The Zaf Group LLC, established in November 2012. Mr. Zafirovski has served as an executive advisor to The Blackstone Group since October 2011. From November 2005 to August 2009, Mr. Zafirovski served as the president and chief executive officer and a director of Nortel Networks Corporation. Prior to that, he was the president and chief operating officer and a director of Motorola, Inc. from July 2002 to January 2005, and remained a consultant to and a director of Motorola until May 2005. He served as executive vice president and president of the Personal Communications Sector of Motorola from June 2000 to July 2002. Prior to joining Motorola, Mr. Zafirovski spent nearly 25 years with General Electric Company, where he served in management positions, including 13 years as president and chief executive officer of five businesses in the consumer, industrial and financial services areas, his most recent being president and chief executive officer of GE Lighting from July 1999 to May 2000. Mr. Zafirovski also serves as a director of The Boeing Company and three private companies. He received a B.A. degree in mathematics from Edinboro University in Pennsylvania.

Basic Compensation

Name Fiscal Year Total

Mark Miller

2,727,350

Charles Alutto

1,839,900

Frank ten Brink

2,139,830

Richard Kogler

2,139,830

Michael Collins

1,192,070

Jack Schuler

--

Thomas Brown

--

Rodney Dammeyer

--

William Hall

--

Jonathan Lord

--

John Patience

--

Ronald Spaeth

--

Michael Zafirovski

--
As Of 30 Dec 2012

Options Compensation

Name Options Value

Mark Miller

924,141 18,552,790

Charles Alutto

24,000 1,534,700

Frank ten Brink

242,820 8,712,970

Richard Kogler

200,173 7,143,878

Michael Collins

83,800 4,332,430

Jack Schuler

0 0

Thomas Brown

0 0

Rodney Dammeyer

0 0

William Hall

0 0

Jonathan Lord

0 0

John Patience

0 0

Ronald Spaeth

0 0

Michael Zafirovski

0 0
Search Stocks